Report Detail
Global Parkinson’s Disease Drugs Market Professional Survey Report 2019
- RnM3789704 |
- 27 September, 2019 |
- Global |
- 106 Pages |
- QYResearch |
- Pharma & Healthcare
Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors.
The global Parkinson’s Disease Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Parkinson’s Disease Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson’s Disease Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Parkinson’s Disease Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Parkinson’s Disease Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Novartis
F. Hoffmann-La Roche
AbbVie
Teva Pharmaceutical Industries
UCB Inc.
STADA Arzneimittel
GlaxoSmithKline
Valeant Pharmaceuticals International
Merck
Impax Laboratories
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Table of Contents
Executive Summary
1 Industry Overview of Parkinson’s Disease Drugs
- 1.1 Definition of Parkinson’s Disease Drugs
- 1.2 Parkinson’s Disease Drugs Segment by Type
- 1.2.1 Global Parkinson’s Disease Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Oral
- 1.2.3 Transdermal
- 1.2.4 Subcutaneous
- 1.2.5 Intestinal Infusion
- 1.3 Parkinson’s Disease Drugs Segment by Applications
- 1.3.1 Global Parkinson’s Disease Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital Pharmacy
- 1.3.3 Retail Pharmacy
- 1.3.4 Online Pharmacy
- 1.4 Global Parkinson’s Disease Drugs Overall Market
- 1.4.1 Global Parkinson’s Disease Drugs Revenue (2014-2025)
- 1.4.2 Global Parkinson’s Disease Drugs Production (2014-2025)
- 1.4.3 North America Parkinson’s Disease Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Parkinson’s Disease Drugs Status and Prospect (2014-2025)
- 1.4.5 China Parkinson’s Disease Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Parkinson’s Disease Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Parkinson’s Disease Drugs Status and Prospect (2014-2025)
- 1.4.8 India Parkinson’s Disease Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Parkinson’s Disease Drugs
- 2.3 Manufacturing Process Analysis of Parkinson’s Disease Drugs
- 2.4 Industry Chain Structure of Parkinson’s Disease Drugs
3 Development and Manufacturing Plants Analysis of Parkinson’s Disease Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Parkinson’s Disease Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Parkinson’s Disease Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Parkinson’s Disease Drugs Production and Capacity Analysis
- 4.2 Parkinson’s Disease Drugs Revenue Analysis
- 4.3 Parkinson’s Disease Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Parkinson’s Disease Drugs Regional Market Analysis
- 5.1 Parkinson’s Disease Drugs Production by Regions
- 5.1.1 Global Parkinson’s Disease Drugs Production by Regions
- 5.1.2 Global Parkinson’s Disease Drugs Revenue by Regions
- 5.2 Parkinson’s Disease Drugs Consumption by Regions
- 5.3 North America Parkinson’s Disease Drugs Market Analysis
- 5.3.1 North America Parkinson’s Disease Drugs Production
- 5.3.2 North America Parkinson’s Disease Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Parkinson’s Disease Drugs Import and Export
- 5.4 Europe Parkinson’s Disease Drugs Market Analysis
- 5.4.1 Europe Parkinson’s Disease Drugs Production
- 5.4.2 Europe Parkinson’s Disease Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Parkinson’s Disease Drugs Import and Export
- 5.5 China Parkinson’s Disease Drugs Market Analysis
- 5.5.1 China Parkinson’s Disease Drugs Production
- 5.5.2 China Parkinson’s Disease Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Parkinson’s Disease Drugs Import and Export
- 5.6 Japan Parkinson’s Disease Drugs Market Analysis
- 5.6.1 Japan Parkinson’s Disease Drugs Production
- 5.6.2 Japan Parkinson’s Disease Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Parkinson’s Disease Drugs Import and Export
- 5.7 Southeast Asia Parkinson’s Disease Drugs Market Analysis
- 5.7.1 Southeast Asia Parkinson’s Disease Drugs Production
- 5.7.2 Southeast Asia Parkinson’s Disease Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Parkinson’s Disease Drugs Import and Export
- 5.8 India Parkinson’s Disease Drugs Market Analysis
- 5.8.1 India Parkinson’s Disease Drugs Production
- 5.8.2 India Parkinson’s Disease Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Parkinson’s Disease Drugs Import and Export
6 Parkinson’s Disease Drugs Segment Market Analysis (by Type)
- 6.1 Global Parkinson’s Disease Drugs Production by Type
- 6.2 Global Parkinson’s Disease Drugs Revenue by Type
- 6.3 Parkinson’s Disease Drugs Price by Type
7 Parkinson’s Disease Drugs Segment Market Analysis (by Application)
- 7.1 Global Parkinson’s Disease Drugs Consumption by Application
- 7.2 Global Parkinson’s Disease Drugs Consumption Market Share by Application (2014-2019)
8 Parkinson’s Disease Drugs Major Manufacturers Analysis
- 8.1 Novartis
- 8.1.1 Novartis Parkinson’s Disease Drugs Production Sites and Area Served
- 8.1.2 Novartis Product Introduction, Application and Specification
- 8.1.3 Novartis Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 F. Hoffmann-La Roche
- 8.2.1 F. Hoffmann-La Roche Parkinson’s Disease Drugs Production Sites and Area Served
- 8.2.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
- 8.2.3 F. Hoffmann-La Roche Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 AbbVie
- 8.3.1 AbbVie Parkinson’s Disease Drugs Production Sites and Area Served
- 8.3.2 AbbVie Product Introduction, Application and Specification
- 8.3.3 AbbVie Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Teva Pharmaceutical Industries
- 8.4.1 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Production Sites and Area Served
- 8.4.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
- 8.4.3 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 UCB Inc.
- 8.5.1 UCB Inc. Parkinson’s Disease Drugs Production Sites and Area Served
- 8.5.2 UCB Inc. Product Introduction, Application and Specification
- 8.5.3 UCB Inc. Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 STADA Arzneimittel
- 8.6.1 STADA Arzneimittel Parkinson’s Disease Drugs Production Sites and Area Served
- 8.6.2 STADA Arzneimittel Product Introduction, Application and Specification
- 8.6.3 STADA Arzneimittel Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 GlaxoSmithKline
- 8.7.1 GlaxoSmithKline Parkinson’s Disease Drugs Production Sites and Area Served
- 8.7.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.7.3 GlaxoSmithKline Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Valeant Pharmaceuticals International
- 8.8.1 Valeant Pharmaceuticals International Parkinson’s Disease Drugs Production Sites and Area Served
- 8.8.2 Valeant Pharmaceuticals International Product Introduction, Application and Specification
- 8.8.3 Valeant Pharmaceuticals International Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Merck
- 8.9.1 Merck Parkinson’s Disease Drugs Production Sites and Area Served
- 8.9.2 Merck Product Introduction, Application and Specification
- 8.9.3 Merck Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Impax Laboratories
- 8.10.1 Impax Laboratories Parkinson’s Disease Drugs Production Sites and Area Served
- 8.10.2 Impax Laboratories Product Introduction, Application and Specification
- 8.10.3 Impax Laboratories Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Parkinson’s Disease Drugs Market
- 9.1 Global Parkinson’s Disease Drugs Market Trend Analysis
- 9.1.1 Global Parkinson’s Disease Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Parkinson’s Disease Drugs Regional Market Trend
- 9.2.1 North America Parkinson’s Disease Drugs Forecast 2019-2025
- 9.2.2 Europe Parkinson’s Disease Drugs Forecast 2019-2025
- 9.2.3 China Parkinson’s Disease Drugs Forecast 2019-2025
- 9.2.4 Japan Parkinson’s Disease Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Parkinson’s Disease Drugs Forecast 2019-2025
- 9.2.6 India Parkinson’s Disease Drugs Forecast 2019-2025
- 9.3 Parkinson’s Disease Drugs Market Trend (Product Type)
- 9.4 Parkinson’s Disease Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Parkinson’s Disease Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Parkinson’s Disease Drugs. Industry analysis & Market Report on Parkinson’s Disease Drugs is a syndicated market report, published as Global Parkinson’s Disease Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Parkinson’s Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
